在超性阻塞性心肌病症中 Septal 微球栓塞
Emyal Alyaydin1, Rolf Alexander Jánosi1, Peter Luedike1
1Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Essen, Germany.
The American journal of cardiology
|June 25, 2023
概括
隔膜微球栓塞 (SME) 有效地减少左心室外流通道阻塞在心肌缩症患者. 这项研究表明,SME是酒精隔膜切除的安全有效替代方案.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 患有左心室外流通道 (LVOT) 阻塞的高性心肌病 (HCM) 通常通过酒精隔膜切除来治疗.
- 隔膜微球栓塞 (SME) 对LVOT阻塞的安全性和有效性以前没有得到评估.
研究的目的:
- 为了评估隔膜微球栓塞 (SME) 的安全性和有效性,在患有LVOT阻塞的患者中使用75μm微球.
- 为了比较中小企业的结果与已建立的治疗方法,如酒精隔膜切除.
主要方法:
- 在2006年至2021年间接受SME治疗的76名患者的回顾性分析.
- 主要终点:LVOT梯度的减少. 二级终点:周围手术死亡率,导电障碍,接入部位并发症和住院时间.
主要成果:
- 中小企业显著减少了休息 (平均 Δ PG = -71%) 并引起 (平均 Δ PG = -75%) LVOT梯度.
- 术周死亡率为1%,其中7%经历了完整的心房阻塞和5%的入口部位并发症.
- 平均住院时间为13天.
结论:
- 隔膜微球栓塞 (SME) 是一种安全有效的替代治疗方法,用于HCM中LVOT阻塞.
- 需要进一步的前性研究来充分阐明微球使用的优势.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
17
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Cardiomyopathy V: Interprofessional Care
18
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18
Cardiomyopathy VII: Pre and Post Operative Nursing Management
16
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
16
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Mitral Stenosis III: Medical Management
14
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
14


